U.S. Markets close in 47 mins

GSK plc (GSK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
35.74-2.56 (-6.70%)
As of 03:13PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close38.30
Bid35.63 x 1100
Ask35.64 x 1000
Day's Range34.50 - 35.99
52 Week Range32.96 - 47.89
Avg. Volume5,612,263
Market Cap89.906B
Beta (5Y Monthly)0.25
PE Ratio (TTM)15.55
EPS (TTM)2.30
Earnings DateFeb 01, 2017 - Feb 06, 2017
Forward Dividend & Yield2.48 (5.89%)
Ex-Dividend DateMay 19, 2022
1y Target Est61.43
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GSK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GSK plc
    Analyst Report: GSK plcIn the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
    Fair Value
    Economic Moat
    4 hours agoMorningstar
View more